BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 28, 2010
 |  BC Week In Review  |  Company News  |  Deals

GlaxoSmithKline, Kyowa Hakka Kirin Co. Ltd. deal

GlaxoSmithKline received non-exclusive rights to research, develop and commercialize antibodies against undisclosed targets generated using Complegent technology from Kyowa's BioWa Inc. subsidiary. Complegent...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >